{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-073492","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2022-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.904932+00:00","generated_at":"2026-06-21T16:43:42.208726+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"InMed terminates interim CFO Brenda Edwards; promotes Sarah Li to VP Accounting and Controller","bullets":["Brenda Edwards' consulting agreement terminated effective Nov 20, 2022; she served as interim CFO since April 2022.","Sarah Li promoted to VP of Accounting and Controller and Principal Accounting Officer; she was Controller since Jan 2020.","Company in discussions to engage new interim financial leadership (CFO) consulting services.","Press release issued Nov 17, 2022 providing management change update."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-073492","json":"https://secwatch.observer/filing/0001213900-22-073492.json","markdown":"https://secwatch.observer/filing/0001213900-22-073492.md","text":"https://secwatch.observer/filing/0001213900-22-073492.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000121390022073492/0001213900-22-073492-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000121390022073492/ea168928-8k_inmedpharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T16:43:42.208726+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6399b2abe7","claim":"Sarah Li changed role as Vice President of Accounting and Controller and Principal Accounting Officer at InMed Pharmaceuticals Inc..","evidence_excerpt":"The Company’s Controller, Sarah Li, has been promoted to Vice President of Accounting and Controller and Principal Accounting Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390022073492/0001213900-22-073492-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Vice President of Accounting and Controller and Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"d2cec77639","claim":"Brenda Edwards was terminated as Interim Chief Financial Officer at InMed Pharmaceuticals Inc..","evidence_excerpt":"On November 14, 2022, the Company terminated the Consulting Agreement for Brenda Edwards effective November 20, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390022073492/0001213900-22-073492-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}